Huadong Medicine's Oncology Gambit: How Clinical Trial Approvals and AI-Driven ... - AInvest
Chemistry42 platform—a small-molecule generation tool that uses AI to design molecules with desired properties—Huadong is tackling one of oncology's ...
Read the original at AInvest ↗
- Topics
- Healthcare
- Tracked via
- “that uses AI to”